+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Syphilis Immunoassay Diagnostic Market - Global Forecast 2026-2032- Product Image
Syphilis Immunoassay Diagnostic Market - Global Forecast 2026-2032- Product Image
New

Syphilis Immunoassay Diagnostic Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995105
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Syphilis Immunoassay Diagnostic Market continues to evolve as healthcare organizations invest in diagnostic accuracy, improved workflows, and integrated solutions that support effective patient care. Senior decision-makers rely on actionable intelligence to optimize technology investments, procurement approaches, and compliance with changing clinical and regulatory standards within this market.

Market Snapshot: Syphilis Immunoassay Diagnostic Market Overview

In 2025, the Syphilis Immunoassay Diagnostic Market was valued at USD 578.43 million and is expected to grow to USD 611.81 million by 2026. The compound annual growth rate (CAGR) is forecast at 5.95%, with the market projected to reach USD 867.44 million by 2032. This positive trajectory is supported by a shift toward point-of-care diagnostic solutions, technological progression in assay design, and heightened demand for scalable, integrated diagnostic workflows in hospitals, clinics, and public health programs.

Scope & Segmentation

  • Product Types: Automated analyzers suitable for central laboratories, point-of-care devices designed for decentralized testing environments, and semi-automated analyzers that offer a balance between throughput and footprint. Additional product classes include control kits, ready-to-use kits, reagent kits, and software platforms that focus on compliance and integrative data management.
  • Assay Technologies: Chemiluminescence immunoassays, enzyme-linked immunosorbent assays (ELISA), and fluorescence immunoassays. Each technology addresses specific workflow demands and sample compatibility considerations, enabling customization for diverse laboratory and clinical settings.
  • Sample Types: Serum and plasma for high-throughput laboratory testing, and whole blood optimized for rapid, point-of-care diagnostics where immediate results are prioritized.
  • End-User Profiles: Hospitals, diagnostic laboratories, blood banks, and clinics. Each group displays unique procurement strategies, workflow integration needs, and quality benchmarks, calling for adaptive product and support models.
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific. Each region experiences differing infrastructure environments, reimbursement frameworks, and healthcare system maturity that impact adoption and operational focus.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • The market is moving from laboratory-centric diagnostics toward models that incorporate rapid and decentralized testing, meeting the demand for timely results and expanded access to screening services.
  • Manufacturers and suppliers must adjust to increased expectations for system automation, evidence of real-world performance, and interoperability with digital health infrastructure as procurement teams tighten evaluation standards.
  • Segment-specific technology adoption allows organizations to align their diagnostic strategy with operational workflow, optimizing sensitivity, turnaround time, and resource allocation.
  • Public health strategies not only focus on detection but also on linkage to care, which prioritizes solutions effective beyond conventional laboratory settings to support immediate intervention.
  • Regional dynamics—including payment models, infrastructure readiness, and localized procurement requirements—demand tailored market entry and commercial approaches for sustained adoption and customer engagement.
  • Successful differentiation is increasingly achieved through strategic collaborations, regionalized manufacturing, and integrated offerings that combine products and support services throughout the customer lifecycle.

Tariff Impact: Sourcing and Supply Chain Adjustments

Recent changes in United States tariff policies during 2025 have shifted the cost landscape for diagnostic device producers, directly affecting sourcing and procurement methodologies. In response, industry participants have pursued regional and nearshoring assessments, utilized multi-sourcing strategies, and simplified product designs to counteract cost fluctuations. Distributors are implementing extended contract durations and innovative inventory solutions, while manufacturers focus on regional assembly and enhanced supply chain visibility. These adaptations safeguard margins and support consistent clinical supply delivery despite ongoing economic pressure.

Methodology & Data Sources

This market review draws upon insights from expert interviews with laboratory professionals, clinical program leaders, procurement personnel, and regulatory specialists. It incorporates data from peer-reviewed publications, regulatory guidance, and supplier documentation. Analytical methodologies—such as segmentation analysis and scenario modeling—ensure the relevance and precision of the findings and recommendations.

Syphilis Immunoassay Diagnostic Market: Why This Report Matters

  • Enables decision-makers to coordinate product development and procurement activities with nuanced operational and clinical ecosystem demands.
  • Offers in-depth segmentation and regional trend analysis, informing investment decisions and guiding market entry priorities for greater impact.
  • Supports strategic partnerships, seamless compliance management, and accelerated clinical implementation across variable healthcare settings.

Conclusion

The ongoing advancement in syphilis immunoassay diagnostics is anchored by technical refinement, regulatory adherence, and supply chain agility. Organizations delivering comprehensive products with strong support infrastructure are positioned to maintain value and resilience within a rapidly shifting healthcare landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Syphilis Immunoassay Diagnostic Market, by Product Type
8.1. Instruments
8.1.1. Automated Analyzer
8.1.2. Point Of Care Device
8.1.3. Semi-Automated Analyzer
8.2. Kits
8.2.1. Control Kits
8.2.2. Ready-To-Use Kits
8.2.3. Reagent Kits
8.3. Software
9. Syphilis Immunoassay Diagnostic Market, by Technology
9.1. Chemiluminescence Immunoassay
9.2. Enzyme-Linked Immunosorbent Assay
9.3. Fluorescence Immunoassay
10. Syphilis Immunoassay Diagnostic Market, by Sample Type
10.1. Serum Plasma
10.2. Whole Blood
11. Syphilis Immunoassay Diagnostic Market, by End User
11.1. Blood Banks
11.2. Clinics
11.3. Diagnostic Laboratories
11.4. Hospitals
12. Syphilis Immunoassay Diagnostic Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Syphilis Immunoassay Diagnostic Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Syphilis Immunoassay Diagnostic Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Syphilis Immunoassay Diagnostic Market
16. China Syphilis Immunoassay Diagnostic Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Beckman Coulter, Inc.
17.7. Becton Dickinson and Company
17.8. Bio-Rad Laboratories, Inc.
17.9. bioMérieux SA
17.10. bioMérieux SA
17.11. F. Hoffmann-La Roche Ltd
17.12. Ortho Clinical Diagnostics, LLC
17.13. Siemens Healthineers AG
17.14. Thermo Fisher Scientific Inc.
17.15. Trinity Biotech plc
List of Figures
FIGURE 1. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY AUTOMATED ANALYZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY AUTOMATED ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY AUTOMATED ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY POINT OF CARE DEVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY POINT OF CARE DEVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY POINT OF CARE DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SEMI-AUTOMATED ANALYZER, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SEMI-AUTOMATED ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SEMI-AUTOMATED ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CONTROL KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CONTROL KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CONTROL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY READY-TO-USE KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY READY-TO-USE KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY READY-TO-USE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY REAGENT KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY REAGENT KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY REAGENT KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SERUM PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SERUM PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SERUM PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 94. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 95. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 96. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 97. EUROPE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 108. AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 109. AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 110. AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 111. AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. ASEAN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASEAN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. ASEAN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 123. ASEAN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 124. ASEAN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 125. ASEAN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 126. ASEAN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. GCC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GCC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. GCC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 130. GCC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 131. GCC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. GCC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 133. GCC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. BRICS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. BRICS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. BRICS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 144. BRICS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 145. BRICS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. BRICS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 147. BRICS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. G7 SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. G7 SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. G7 SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 151. G7 SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 152. G7 SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. G7 SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 154. G7 SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. NATO SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. NATO SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 157. NATO SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 158. NATO SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 159. NATO SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. NATO SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 161. NATO SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 167. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 168. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 171. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 173. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 174. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 175. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 176. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Syphilis Immunoassay Diagnostic market report include:
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Ortho Clinical Diagnostics, LLC
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 611.81 Million
Forecasted Market Value ( USD ) by 2032 $ 867.44 Million
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Syphilis Immunoassay Diagnostics Market Report 2025 - Product Image

Syphilis Immunoassay Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Syphilis Immunoassay Diagnostics - Global Strategic Business Report - Product Image

Syphilis Immunoassay Diagnostics - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Syphilis Immunoassay Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Syphilis Immunoassay Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Syphilis Immunoassay Diagnostics Market Report and Forecast 2025-2034 - Product Image

Syphilis Immunoassay Diagnostics Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Immunoassay Analyzers Market - Global Forecast 2026-2032 - Product Image

Immunoassay Analyzers Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From

About the Syphilis Immunoassay Market

The Syphilis Immunoassay market is a segment of the broader In Vitro Diagnostics (IVD) sector that focuses on the detection and diagnosis of syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. Immunoassays are laboratory techniques used to detect specific antigens or antibodies in serum or plasma samples. These assays are essential diagnostic tools in the management of syphilis, allowing for early detection, confirmation of infection, and monitoring of treatment efficacy. This market includes both manual and automated testing platforms that can deliver rapid results and high-throughput screening. Due to the importance of timely and accurate syphilis screening, investments in research and development have led to the advancement of immunoassay technologies, with an emphasis on improving sensitivity, specificity, and ease of use. Several companies operate within the Syphilis Immunoassay market, each offering various testing solutions to suit different healthcare settings and diagnostic needs. Some prominent players in this market are Abbott Laboratories, which provides a range of diagnostic equipment and tests, Roche Diagnostics with their automated immunoassay systems, Siemens Healthineers known for their innovative laboratory diagnostics, Bio-Rad Laboratories offering a variety of immunoassay platforms, and Danaher Corporation, which operates under various brand names and has a diverse portfolio of diagnostic solutions. These companies are pivotal in shaping the landscape of syphilis diagnostics and continue to contribute to public health efforts through their products and services Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.